Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.29%
IXIC
-0.40%
FTSE
-0.42%
N225
+1.71%
AXJO
+0.73%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

About

What does SLS do?
SELLAS Life Sciences Group, a clinical stage biopharmaceutical company based in New York, develops immunotherapeutics for cancer, including galinpepimut-S and SLS009. The company went public in 2008 and employs 16 staff.
Sector
💻 Health Care
IPO
CEO
Employees
15
Headquarters
New York, USA
Website
http://www.sellaslifesciences.com

Key Stats

Market Cap
162.64M
Dividend Yield
0.00%
P/E Ratio
-6.19
EPS
-0.52
Revenue
-
Avg. Volume
1.70M

Recently from Cashu

publisher logo
Cashu

Jhancarlos Gonzalez Excels at SLS Cleveland Takeover: A Bright Future for SELLAS Life Sciences

3 days ago
publisher logo
Cashu

SELLAS Life Sciences Group Celebrates Cleveland's Cultural Takeover with Street League Skateboarding Event

29 days ago
publisher logo
Cashu

SELLAS Life Sciences Group Supports SLS Championship Tour Celebrating Culture and Skateboarding in Cleveland

about 1 month ago
Stocks
Health Care
sls
SELLAS Life Sciences Group
NASDAQ: SLS
+0.06 (+4.19%)
1.615
USD
At close at Aug 15, 20:43 UTC
Summary
News
Signals
Benchmarks
Financials